Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Efficacy and tolerance profile of thalidomide in cutaneous lupus erythematosus: A systematic review and meta-analysis
François Chasset, T. Tounsi, E. Cesbron, et al.
Journal of the American Academy of Dermatology (2017) Vol. 78, Iss. 2, pp. 342-350.e4
Closed Access | Times Cited: 67

Showing 1-25 of 67 citing articles:

2019 update of the EULAR recommendations for the management of systemic lupus erythematosus
Antonis Fanouriakis, Myrto Kostopoulou, Alessia Alunno, et al.
Annals of the Rheumatic Diseases (2019) Vol. 78, Iss. 6, pp. 736-745
Open Access | Times Cited: 1706
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update
Antonis Fanouriakis, Myrto Kostopoulou, Jeanette Andersen, et al.
Annals of the Rheumatic Diseases (2023) Vol. 83, Iss. 1, pp. 15-29
Open Access | Times Cited: 368
Cutaneous lupus erythematosus: a review of etiopathogenic, clinical, diagnostic and therapeutic aspects
Everton Carlos Siviero do Vale, Lucas Campos Garcia
Anais Brasileiros de Dermatologia (2023) Vol. 98, Iss. 3, pp. 355-372
Open Access | Times Cited: 31
Cutaneous lupus erythematosus: A review of the literature
Stephanie Blake, Benjamin S. Daniel
International Journal of Women’s Dermatology (2019) Vol. 5, Iss. 5, pp. 320-329
Open Access | Times Cited: 40
Treatment of cutaneous lupus erythematosus: current approaches and future strategies
Hong Shi, Jóhann E. Guðjónsson, J. Michelle Kahlenberg
Current Opinion in Rheumatology (2020) Vol. 32, Iss. 3, pp. 208-214
Open Access | Times Cited: 38
Interventions for cutaneous disease in systemic lupus erythematosus
C Whitney Hannon, Collette McCourt, Hermenio Lima, et al.
Cochrane library (2021) Vol. 2021, Iss. 3
Open Access | Times Cited: 30
Cutaneous Lupus Erythematosus: Current and Future Pathogenesis-Directed Therapies.
Alicia J. Little, Matthew D. Vesely
(2020) Vol. 93, Iss. 1, pp. 81-95
Closed Access | Times Cited: 32
Current Concepts and Future Approaches in the Treatment of Cutaneous Lupus Erythematosus: A Comprehensive Review
François Chasset, Camille Françès
Drugs (2019) Vol. 79, Iss. 11, pp. 1199-1215
Open Access | Times Cited: 31
Advances in the pharmacological management of systemic lupus erythematosus
Alexander Tsoi, Dionysis Nikolopoulos, Ioannis Parodis
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 6, pp. 705-716
Open Access | Times Cited: 3
Advances in the treatment of systemic lupus erythematosus: From back to the future, to the future and beyond
Renaud Felten, Florence Scher, Jean Sibilia, et al.
Joint Bone Spine (2018) Vol. 86, Iss. 4, pp. 429-436
Open Access | Times Cited: 31
Advances in Disease Mechanisms and Translational Technologies: Clinicopathologic Significance of Inflammasome Activation in Autoimmune Diseases
J. Michelle Kahlenberg, Insoo Kang
Arthritis & Rheumatology (2019) Vol. 72, Iss. 3, pp. 386-395
Open Access | Times Cited: 29
Thalidomide and Lenalidomide for Refractory Systemic/Cutaneous Lupus Erythematosus Treatment
Emily Figueiredo Neves Yuki, Clóvis A. Silva, Nádia Emi Aikawa, et al.
JCR Journal of Clinical Rheumatology (2019) Vol. 27, Iss. 6, pp. 248-259
Closed Access | Times Cited: 23
An update on the management of refractory cutaneous lupus erythematosus
Alice Verdelli, Alberto Corrà, Elena Biancamaria Mariotti, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 13
Connective Tissue Disease
Anthony P. Fernandez
Dermatologic Clinics (2018) Vol. 37, Iss. 1, pp. 37-48
Closed Access | Times Cited: 22
Treatment Update in Systemic Lupus Erythematous
Alberta Hoi, Eric F. Morand
Rheumatic Disease Clinics of North America (2021) Vol. 47, Iss. 3, pp. 513-530
Closed Access | Times Cited: 17
Risk of thromboembolic events in patients treated with thalidomide for cutaneous lupus erythematosus: A multicenter retrospective study
E. Cesbron, D. Bessis, M. Jachiet, et al.
Journal of the American Academy of Dermatology (2018) Vol. 79, Iss. 1, pp. 162-165
Closed Access | Times Cited: 20
Advancing understanding, diagnosis, and therapies for cutaneous lupus erythematosus within the broader context of systemic lupus erythematosus
Kristen L. Chen, Rebecca L. Krain, Victoria P. Werth
F1000Research (2019) Vol. 8, pp. 332-332
Open Access | Times Cited: 19
Efficacy of Thalidomide in Discoid Lupus Erythematosus: Insights into the Molecular Mechanisms
Sandra Domingo, Cristina Solé, Teresa Moliné, et al.
Dermatology (2020) Vol. 236, Iss. 5, pp. 467-476
Open Access | Times Cited: 14
Recent Insight on the Management of Lupus Erythematosus Alopecia
Karishma Desai, Mariya Miteva
Clinical Cosmetic and Investigational Dermatology (2021) Vol. Volume 14, pp. 333-347
Open Access | Times Cited: 12
S2k guideline: Diagnosis and management of cutaneous lupus erythematosus – Part 2: Therapy, risk factors and other special topics
Margitta Worm, Miriam Zidane, Lisa Eisert, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2021) Vol. 19, Iss. 9, pp. 1371-1395
Open Access | Times Cited: 12
Thalidomide Attenuates Skin Lesions and Inflammation in Rosacea-Like Mice Induced by Long-Term Exposure of LL-37
Yumeng Kang, Chuan‐Xi Zhang, Yang He, et al.
Drug Design Development and Therapy (2022) Vol. Volume 16, pp. 4127-4138
Open Access | Times Cited: 8
Management of cutaneous lupus erythematosus
Benjamin F. Chong, Victoria P. Werth
Elsevier eBooks (2024), pp. 802-809
Closed Access | Times Cited: 1
Expert Perspective: An Evidence‐Based Approach to Refractory Cutaneous Lupus Erythematosus
Robert Borucki, Victoria P. Werth
Arthritis & Rheumatology (2020) Vol. 72, Iss. 11, pp. 1777-1785
Closed Access | Times Cited: 10
Candidate drug replacements for quinacrine in cutaneous lupus erythematosus
Daisy Yan, Robert Borucki, Richard D. Sontheimer, et al.
Lupus Science & Medicine (2020) Vol. 7, Iss. 1, pp. e000430-e000430
Open Access | Times Cited: 10
Thalidomide and discoid lupus erythematosus: case series and review of literature
Giovanna Malara, Chiara Verduci, Maria Altomonte, et al.
Drugs in Context (2022) Vol. 11, pp. 1-10
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top